Nylia 1/35 Kit
Product Images NDC 65862-898

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nylia 1/35 (NDC 65862-898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Norethindroneethinyl Fig1)

A bar chart depicting circulatory disease mortality rates per 100,000 woman-years by age groups, smoking status, and oral contraceptive use. The x-axis shows age groups (15-24, 25-34, 35-44, 45+), and the y-axis shows mortality rate. Four categories are compared: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers) with varying bar heights illustrating mortality differences.*

FDA Label Image

Elliona Figure 2 (Norethindroneethinyl Fig2)

A forest plot chart showing effect estimates (OR/RR) with confidence intervals from various studies on a horizontal scale ranging from -1.5 to 2. Study names and years are listed on the left, with effect estimates and confidence intervals numerically displayed on the right. The vertical reference line at 1 indicates no effect.*

FDA Label Image

Elliona Figure 3 (Norethindroneethinyl Fig3)

A weekly pill schedule diagram for Nylia 1/35, showing four rows labeled by week (Week 1 to Week 4) and days of the week from Sunday to Saturday. The first three weeks are marked with peach-colored circles representing active tablets, while the fourth week has green-colored circles for inactive tablets. The diagram includes directional arrows indicating the pill-taking order from left to right across each row.*

FDA Label Image

Elliona Figure 4 (Norethindroneethinyl Fig4)

An instructional diagram showing how to apply a day label to a Nylia 1/35 (Norethindrone and Ethinyl Estradiol) kit. The illustration features a hand peeling off a label displaying the days of the week, with an example of how to place it above a four-week tablet grid labeled by week and color-coded by Pills: peach for weeks 1-3 and green for week 4.*

FDA Label Image

Elliona Figure 5 (Norethindroneethinyl Fig5)

Illustration showing how to apply a day-of-the-week label on a Nylia 1/35 contraceptive tablet kit. It depicts a hand peeling a label with days MON through SUN to place on the tablet pack, which contains four rows of round tablets labeled by week and color-coded as Peach for weeks 1-3 and Green for week 4.*

FDA Label Image

Elliona Figure 6 (Norethindroneethinyl Fig6)

An illustrated weekly pill schedule for the Nylia 1/35 kit containing Norethindrone and Ethinyl Estradiol tablets. The diagram shows four rows of circular pill slots aligned under weekdays Sunday through Saturday. The first three rows labeled 'Peach' correspond to Weeks 1 to 3, while the fourth row labeled 'Green' corresponds to Week 4. Arrows indicate the starting point at Sunday of Week 1.*

FDA Label Image

Package Label-principal Display Panel – 1 mg/0.035 mg Pouch Label (Norethindroneethinyl Fig7)

An instructional diagram showing a hand placing a day label strip (MON to SUN) above a Nylia 1/35 oral contraceptive tablet blister pack. The blister pack is divided into four rows labeled Week 1 (peach), Week 2 (peach), Week 3 (peach), and Week 4 (green), indicating days to organize pill intake. The label strip is to be peeled and placed at the top for daily tracking.*

FDA Label Image

Package Label-principal Display Panel – 1 mg/0.035 mg Pouch Carton (Norethindroneethinyl Fig8)

Nylia 1/35 kit packaging label for Norethindrone and Ethinyl Estradiol tablets, USP, 1 mg/0.035 mg. The label shows a 28-day regimen pouch containing 28 tablets, labeled for prescription use only. It is distributed by Aurobindo Pharma USA, Inc., with the product made in India. The label includes warnings and barcode details.*

FDA Label Image

Norethindroneethinyl Fig9

Packaging label for Nylia 1/35, containing Norethindrone and Ethinyl Estradiol tablets, USP, 1 mg/0.035 mg. The kit includes 6 pouches each containing 28 tablets, distributed by Aurobindo Pharma USA, Inc. The label states usual dosage, storage conditions, and important usage information. Made in India by Aurobindo Pharma Limited.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str)

Chemical structure diagram showing the molecular structures of Norethindrone and Ethinyl Estradiol, the active ingredients in Nylia 1/35. The illustration depicts the steroid frameworks with specific functional groups for each compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.